Generate a tailored SOP for Dr. Owen Rackham. Improve your application with a focused, well-structured draft.
Dr. Owen Rackham is a leading expert in developing computational approaches for cell reprogramming and disease-gene associations. His group specializes in identifying key regulators that control cell fate and discovering novel routes for cell conversion into targeted therapies. Dr. Rackham has extensive expertise in high-throughput sequencing data, biological network analysis, and statistics. He completed his PhD in complexity sciences in 2012 and became an MRC career development fellow at Imperial College London. In 2015, he joined Duke-NUS Medical School as a senior research fellow, where he established his research group in 2016, focusing on data-driven tools for cell reprogramming in relation to diseases. He became jointly appointed at Southampton University in 2020 as an Associate Professor of Systems Biology and leads the Cell and Molecular Medicine theme at the Alan Turing Institute. His work has primarily involved patent applications and licensing deals, and he co-founded the spin-out company Mogrify Ltd., which develops cell therapy products for clinical applications. Dr. Rackham's current research projects include using AI to extend the universe of cell types, supported by the Biotechnology & Biological Sciences Research Council. He aims to transform hypothesis-driven research by utilizing biological big data to test and generate hypotheses, particularly focusing on understanding how genes and drugs coordinate changes in cellular phenotypes to treat diseases.